Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
11.83
-0.09 (-0.76%)
Aug 5, 2026, 4:00 PM EDT - Market closed

Replimune Group Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Income
-319.92-319.92-261.63-234.77-177.08-118.31
Net Income
-313.94-313.94-247.3-215.79-174.28-118.04
Earnings Per Share
-3.38-3.38-3.07-3.24-2.99-2.26
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
268.89268.89483.8420.67583.39395.66
Total Debt
111.59111.5976.1775.8760.7632.84
Net Cash (Debt)
157.3157.3407.64344.8522.63362.82
Net Cash Growth
-61.41%-61.41%18.22%-34.03%44.05%-18.10%
Net Cash Per Share
1.701.705.065.188.986.95

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-280.34-280.34-192.25-185.47-128.05-82.18
Capital Expenditures
-4.22-4.22-6.69-5.66-2.27-2.34
Free Cash Flow
-284.57-284.57-198.94-191.13-130.32-84.52
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.